These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31303211)

  • 1. Canine visceral leishmaniasis biomarkers and their employment in vaccines.
    Giunchetti RC; Silveira P; Resende LA; Leite JC; Melo-Júnior OAO; Rodrigues-Alves ML; Costa LM; Lair DF; Chaves VR; Soares IDS; de Mendonça LZ; Lanna MF; Ribeiro HS; Maia-Gonçalves AA; Santos TAP; Roatt BM; Aguiar-Soares RDO; Vitoriano-Souza J; das Dores Moreira N; Mathias FAS; Cardoso JMO; Coura-Vital W; Galdino AS; Viana KF; Martins-Filho OA; Silveira-Lemos DD; Dutra WO; Reis AB
    Vet Parasitol; 2019 Jul; 271():87-97. PubMed ID: 31303211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of immunogenicity by live attenuated Leishmania donovani centrin deleted parasites in dogs.
    Fiuza JA; Santiago Hda C; Selvapandiyan A; Gannavaram S; Ricci ND; Bueno LL; Bartholomeu DC; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2013 Apr; 31(14):1785-92. PubMed ID: 23398933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotype patterns of immunoglobulins: hallmarks for clinical status and tissue parasite density in Brazilian dogs naturally infected by Leishmania (Leishmania) chagasi.
    Reis AB; Teixeira-Carvalho A; Vale AM; Marques MJ; Giunchetti RC; Mayrink W; Guerra LL; Andrade RA; Corrêa-Oliveira R; Martins-Filho OA
    Vet Immunol Immunopathol; 2006 Aug; 112(3-4):102-16. PubMed ID: 16621021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interpretation of laboratory data during cryptic leishmaniasis in dog].
    Gravino AE
    Parassitologia; 2004 Jun; 46(1-2):227-9. PubMed ID: 15305723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis.
    Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA
    Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic and compartmentalized immune response in canine visceral leishmaniasis.
    Reis AB; Martins-Filho OA; Teixeira-Carvalho A; Giunchetti RC; Carneiro CM; Mayrink W; Tafuri WL; Corrêa-Oliveira R
    Vet Immunol Immunopathol; 2009 Mar; 128(1-3):87-95. PubMed ID: 19054576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic features of circulating leucocytes as immunological markers for clinical status and bone marrow parasite density in dogs naturally infected by Leishmania chagasi.
    Reis AB; Teixeira-Carvalho A; Giunchetti RC; Guerra LL; Carvalho MG; Mayrink W; Genaro O; Corrêa-Oliveira R; Martins-Filho OA
    Clin Exp Immunol; 2006 Nov; 146(2):303-11. PubMed ID: 17034583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunology of canine leishmaniasis.
    Barbiéri CL
    Parasite Immunol; 2006 Jul; 28(7):329-37. PubMed ID: 16842269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune response dynamics and Lutzomyia longipalpis exposure characterize a biosignature of visceral leishmaniasis susceptibility in a canine cohort.
    Solcà MDS; Arruda MR; Leite BMM; Mota TF; Rebouças MF; de Jesus MS; Amorim LDAF; Borges VM; Valenzuela J; Kamhawi S; Veras PST; Fraga DBM; Brodskyn CI
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009137. PubMed ID: 33617528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological profile of resistance and susceptibility in naturally infected dogs by Leishmania infantum.
    de Almeida Leal GG; Roatt BM; de Oliveira Aguiar-Soares RD; Carneiro CM; Giunchetti RC; Teixeira-Carvalho A; Martins-Filho OA; Francisco AF; Cardoso JM; Mathias FA; Correa-Oliveira R; Carneiro M; Coura-Vital W; Reis AB
    Vet Parasitol; 2014 Oct; 205(3-4):472-82. PubMed ID: 25234767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the influence of tissue parasite density on hematological and phenotypic cellular parameters of circulating leukocytes and splenocytes during ongoing canine visceral leishmaniasis.
    Guerra LL; Teixeira-Carvalho A; Giunchetti RC; Martins-Filho OA; Reis AB; Corrêa-Oliveira R
    Parasitol Res; 2009 Feb; 104(3):611-22. PubMed ID: 18985385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of antigen-specific T cell responses from dogs infected with Leishmania (L.) infantum by use of vaccine associated TLR-agonist adjuvant.
    Schaut RG; Grinnage-Pulley TL; Esch KJ; Toepp AJ; Duthie MS; Howard RF; Reed SG; Petersen CA
    Vaccine; 2016 Oct; 34(44):5225-5234. PubMed ID: 27665354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of cytokine gene expression and parasite load in PBMC in Leishmania infantum experimentally infected dogs.
    Sanchez-Robert E; Altet L; Alberola J; Rodriguez-Cortés A; Ojeda A; López-Fuertes L; Timon M; Sanchez A; Francino O
    Vet Immunol Immunopathol; 2008 Sep; 125(1-2):168-75. PubMed ID: 18514330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.
    Roatt BM; Aguiar-Soares RD; Vitoriano-Souza J; Coura-Vital W; Braga SL; Corrêa-Oliveira R; Martins-Filho OA; Teixeira-Carvalho A; de Lana M; Figueiredo Gontijo N; Marques MJ; Giunchetti RC; Reis AB
    PLoS One; 2012; 7(11):e49780. PubMed ID: 23189161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.
    Shahbazi M; Zahedifard F; Taheri T; Taslimi Y; Jamshidi S; Shirian S; Mahdavi N; Hassankhani M; Daneshbod Y; Zarkesh-Esfahani SH; Papadopoulou B; Rafati S
    PLoS One; 2015; 10(7):e0132794. PubMed ID: 26197085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathology, parasite density and cell phenotypes of the popliteal lymph node in canine visceral leishmaniasis.
    Giunchetti RC; Martins-Filho OA; Carneiro CM; Mayrink W; Marques MJ; Tafuri WL; Corrêa-Oliveira R; Reis AB
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):23-33. PubMed ID: 17723246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.
    Resende LA; Aguiar-Soares RD; Gama-Ker H; Roatt BM; Mendonça LZ; Alves ML; Silveira-Lemos Dd; Corrêa-Oliveira R; Martins-Filho OA; Araújo MS; Fujiwara RT; Gontijo NF; Reis AB; Giunchetti RC
    PLoS One; 2016; 11(8):e0161169. PubMed ID: 27556586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.